For many years, researchers have argued that preeclampsia is a clinical syndrome of the placenta resulting from an immune response to the foreign organ. The theory is that preeclampsia typically presents with symptoms affecting the blood vessels, such as hypertension, proteinuria, and organ dysfunction, but is actually the result of earlier inflammation, endothelial damage (damage that affects the interior lining of the blood vessels), and reduced blood flow to vital organs.
This research article asks the question: is the placenta the reason preeclampsia occurs, or is it just one more organ affected by an underlying cardiovascular disease? The authors make the argument that preeclampsia could be caused by an underlying cardiovascular disease which is not yet fully understood, with the placental issues only being a secondary effect (along with other organs). Proposing that preeclampsia starts with cardiovascular issues could then influence how preeclampsia screening, diagnostic and prevention strategies would be managed by a woman’s care providers. Given the annual impact the disease has on pregnancies in the US and globally, this viewpoint could help increase focus on prevention strategies.
Take home message: A clear understanding and acceptance of the role of the cardiovascular system in preeclampsia is needed.
Link: https://www.ajog.org/article/S0002-9378(20)31198-4/fulltext
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials Finding strategies for preventing preeclampsia is a top priority in...
Masked Pregnancy-Associated Hypertension as a Predictor of Adverse Outcomes Pregnant women who have risk factors for preeclampsia may be advised by their health care provider to monitor their...
Preeclampsia Prevention by Timed Birth at Term In this study, researchers looked at different ways to find out if a pregnant woman might get preeclampsia at term (>37 weeks) and when would be...
Polygenic prediction of preeclampsia and gestational hypertension All humans have near-identical DNA sequences across the estimated 6 billion-letter code that makes up the human genome. However, slig...
Noninvasive preeclampsia prediction using plasma cell-free RNA signatures. Messenger ribonucleic acid (mRNA) is a molecule that contains the instructions to tell cells how to make proteins. mRNA is m...